Association of Inhibin B Serum Levels with Parameters of Follicular Response in a Randomized Controlled Trial Comparing GnRH Agonist Versus Antagonist Protocols for Ovarian Hyperstimulation

[1]  M. Tally,et al.  Inhibin B Predicts Oocyte Number and the Ratio IGF-I/IGFBP-1 May Indicate Oocyte Quality During Ovarian Hyperstimulation for In Vitro Fertilization , 2003, Journal of Assisted Reproduction and Genetics.

[2]  R. Fanchin,et al.  Luteal estradiol administration strengthens the relationship between day 3 follicle-stimulating hormone and inhibin B levels and ovarian follicular status. , 2003, Fertility and sterility.

[3]  W. Robertson,et al.  Day 5 inhibin B levels in a treatment cycle are predictive of IVF outcome. , 2002, Human reproduction.

[4]  M. Heineman,et al.  Ovarian reserve testing and the use of prognostic models in patients with subfertility. , 2001, Human reproduction update.

[5]  G. Lambert-Messerlian,et al.  Inhibin B response to EFORT is associated with the outcome of oocyte retrieval in the subsequent in vitro fertilization cycle. , 2000, Fertility and sterility.

[6]  R. Casamitjana,et al.  Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome. , 2000, Human reproduction.

[7]  B. Fauser,et al.  Regulation of follicle development and novel approaches to ovarian stimulation for IVF. , 2000, Human reproduction update.

[8]  R. Casamitjana,et al.  Day 5 inhibin B serum concentrations as predictors of assisted reproductive technology outcome in cycles stimulated with gonadotrophin-releasing hormone agonist-gonadotrophin treatment. , 2000, Human reproduction.

[9]  G. Borm,et al.  Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. The European Orgalutran Study Group. , 2000, Human reproduction.

[10]  P. Devroey,et al.  Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group. , 2000, Human reproduction.

[11]  N. Groome,et al.  Relationship between serum inhibin A and B and ovarian follicle development after a daily fixed dose administration of recombinant follicle-stimulating hormone. , 2000, The Journal of clinical endocrinology and metabolism.

[12]  T. Hillensjö,et al.  Is there a difference in the function of granulosa-luteal cells in patients undergoing in-vitro fertilization either with gonadotrophin-releasing hormone agonist or gonadotrophin-releasing hormone antagonist? , 1999, Human reproduction.

[13]  D. Cramer,et al.  Inhibin A and inhibin B reflect ovarian function in assisted reproduction but are less useful at predicting outcome. , 1999, Human reproduction.

[14]  D. Schoenfeld,et al.  Frequency modulation of follicle-stimulating hormone (FSH) during the luteal-follicular transition: evidence for FSH control of inhibin B in normal women. , 1997, The Journal of clinical endocrinology and metabolism.

[15]  S. Muttukrishna,et al.  Circulating inhibins and activin A during GnRH‐analogue down‐regulation and ovarian hyperstimulation with recombinant FSH for in‐vitro fertilization‐embryo transfer , 1996, Clinical endocrinology.

[16]  A. Mcneilly,et al.  Measurement of dimeric inhibin B throughout the human menstrual cycle. , 1996, The Journal of clinical endocrinology and metabolism.

[17]  M. Jakubowski,et al.  Gonadotropin-releasing hormone receptor gene expression in human ovary and granulosa-lutein cells. , 1995, The Journal of clinical endocrinology and metabolism.

[18]  D Jordan,et al.  GnRH receptors in human granulosa cells: anatomical localization and characterization by autoradiographic study. , 1989, Endocrinology.

[19]  J. Vaughan,et al.  Hormonal regulation of granulosa cell inhibin biosynthesis. , 1986, Endocrinology.

[20]  K. Catt,et al.  Gonadotropin-releasing hormone analogue binds to luteal cells and inhibits progesterone production , 1979, Nature.

[21]  D. Baird,et al.  Prospective analysis of the relationships between the ovarian follicle cohort and basal FSH concentration, the inhibin response to exogenous FSH and ovarian follicle number at different stages of the normal menstrual cycle and after pituitary down-regulation. , 2003, Human reproduction.

[22]  R. Seufert,et al.  Concentrations of inhibins and activin in women undergoing stimulation with recombinant follicle-stimulating hormone for in vitro fertilization treatment. , 2001, Fertility and sterility.

[23]  T. European Middle East Orgalutran Study Group*.  Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation. , 2001, Human reproduction.

[24]  Z. Shoham.  Ovarian stimulation. , 1999, Human reproduction.

[25]  J. Findlay,et al.  An update on the roles of inhibin, activin, and follistatin as local regulators of folliculogenesis. , 1993, Biology of reproduction.